Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period
Go back to Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period| Elite Pharmaceuticals (NASDAQ: LI) | Delayed: 12.82 -0.39 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.21 | 52 Week High | $35.22 | |||
| Open | $12.87 | 52 Week Low | $0.98 | |||
| Day High | $13.10 | P/E | N/A | |||
| Day Low | $12.82 | EPS | $-0.86 | |||
| Volume | 2,910,304 | |||||
| NASDAQ OMX Group (NASDAQ: NDAQ) | Delayed: 82.61 +0.37 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.24 | 52 Week High | $71.92 | |||
| Open | $82.75 | 52 Week Low | $54.62 | |||
| Day High | $83.40 | P/E | 36.72 | |||
| Day Low | $81.49 | EPS | $2.25 | |||
| Volume | 5,140,888 | |||||
